日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Navicixizumab联合紫杉醇治疗铂类耐药卵巢癌、原发性腹膜癌或输卵管癌患者的Ib期研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01801
Fu, Siqing; Corr, Bradley R; Culm-Merdek, Kerry; Mockbee, Colleen; Youssoufian, Hagop; Stagg, Robert; Naumann, R Wendel; Wenham, Robert M; Rosengarten, Rafael D; Benjamin, Laura; Hamilton, Erika Paige; Moore, Kathleen N
肿瘤
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Enhancement of human plasma glucosylceramide assay sensitivity using delipidized plasma

利用脱脂血浆提高人血浆葡糖基神经酰胺测定的灵敏度

期刊:Molecular Genetics and Metabolism Reports
影响因子:1.9
doi:10.1016/j.ymgmr.2016.07.004
Zheng, Kefei; Ji, Allena; Chung, Lee Lee; Culm-Merdek, Kerry; Liu, Hanlan; Richards, Susan; Sung, Crystal
发表日期：2016
文献求助 收藏

Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency

酸性鞘磷脂酶缺乏症患者体内奥利普酶α剂量递增的成功案例

期刊:Molecular Genetics and Metabolism
影响因子:3.5
doi:10.1016/j.ymgme.2015.05.013
Wasserstein, Melissa P; Jones, Simon A; Soran, Handrean; Diaz, George A; Lippa, Natalie; Thurberg, Beth L; Culm-Merdek, Kerry; Shamiyeh, Elias; Inguilizian, Haig; Cox, Gerald F; Puga, Ana Cristina
发表日期：2015
文献求助 收藏